Harrow, Inc. announced an innovative initiative to expand access and affordability for its ophthalmic pharmaceutical products. This program includes targeted price reductions for several Harrow products, aiming to make essential medications more accessible to patients.
As part of this effort, Harrow has partnered with GoodRx, a leading prescription savings platform in the U.S. This collaboration will provide patients with discounts on select Harrow products, further reducing out-of-pocket costs and enhancing affordability.
The initiative underscores Harrow's commitment to addressing critical challenges in healthcare by ensuring that life-changing medications are both accessible and affordable. By reducing financial barriers, the company aims to improve patient compliance and drive better health outcomes across its product portfolio.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.